The systemic treatment of advanced and metastatic bladder cancer
- 1 August 2003
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 4 (8) , 489-497
- https://doi.org/10.1016/s1470-2045(03)01168-9
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Current understanding of the biology of advanced bladder cancerCancer, 2003
- High-risk metastatic urothelial cancer: chances for cure?Current Opinion in Urology, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinumEuropean Journal Of Cancer, 1998
- Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy: Nordic Cystectomy Trial 1Journal of Urology, 1996
- A Randomized Trial of Radical Cystectomy Versus Radical Cystectomy Plus Cisplatin, Vinblastine and Methotrexate Chemotherapy for Muscle Invasive Bladder CancerJournal of Urology, 1996
- Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentationsUrology, 1995
- M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladderEuropean Journal of Cancer and Clinical Oncology, 1991
- Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: Cause for concernUrology, 1989